Aggressive forms of periodontitis secondary to systemic disorders

Periodontology 2000

Volumn 65, Issue 1, 2014, Pages 134-148

  Khocht, Ahmed ^a   Albandar, Jasim M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGGRESSIVE PERIODONTITIS; COMPLICATION; DISEASE COURSE; DISEASES; HUMAN; IMMUNOLOGY; INBORN ERROR OF METABOLISM; LEUKOCYTE DISORDER; NEUTROPHIL; PATHOLOGY; SYNDROME;

AGGRESSIVE PERIODONTITIS; DISEASE; DISEASE PROGRESSION; HUMANS; LEUKOCYTE DISORDERS; METABOLISM, INBORN ERRORS; NEUTROPHILS; SYNDROME;

EID: 84898850750     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12015     Document Type: Article

References (113)

1. Abdulsalam AH, Sabeeh N, Bain BJ. Bone marrow aspirate in Chediak-Higashi syndrome. Am J Hematol 2012: 87: 100.
2. Ahmadian L, Monzavi A, Arbabi R, Hashemi HM. Full-mouth rehabilitation of an edentulous patient with Papillon-Lefèvre syndrome using dental implants: a clinical report. J Prosthodont 2011: 20: 643-648.
3. Ahuja V, Shin RH, Mudgil A, Nanda V, Schoor R. Papillon-Lefèvre syndrome: a successful outcome. J Periodontol 2005: 76: 1996-2001.
4. Akinci O, Mihci E, Tacoy S, Kardelen F, Keser I, Aslan M. Neutrophil oxidative metabolism in Down syndrome patients with congenital heart defects. Environ Mol Mutagen 2010: 51: 57-63.
5. Alaluusua S, Kivitie-Kallio S, Wolf J, Haavio ML, Asikainen S, Pirinen S. Periodontal findings in Cohen syndrome with chronic neutropenia. J Periodontol 1997: 68: 473-478.
6. Albandar JM, Khattab R, Monem F, Barbuto SM, Paster BJ. The subgingival microbiota of Papillon-Lefèvre syndrome. J Periodontol 2012: 83: 902-908.
7. Amano A, Kishima T, Akiyama S, Nakagawa I, Hamada S, Morisaki I. Relationship of periodontopathic bacteria with early-onset periodontitis in Down's syndrome. J Periodontol 2001: 72: 368-373.
8. Amano A, Kishima T, Kimura S, Takiguchi M, Ooshima T, Hamada S, Morisaki I. Periodontopathic bacteria in children with Down syndrome. J Periodontol 2000: 71: 249-255.
9. Amaral Loureiro AC, Oliveira Costa F, Eustaquio da Costa J. The impact of periodontal disease on the quality of life of individuals with Down syndrome. Downs Syndr Res Pract 2007: 12: 50-54.
10. Ancliff PJ, Gale RE, Linch DC. Neutrophil elastase mutations in congenital neutropenia. Hematology 2003: 8: 165-171.
11. Antonio AG, Alcantara PC, Ramos ME, de Souza IP. The importance of dental care for a child with severe congenital neutropenia: a case report. Spec Care Dentist 2010: 30: 261-265.
12. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999: 4: 1-6.
13. Bailleul-Forestier I, Monod-Broca J, Benkerrou M, Mora F, Picard B. Generalized periodontitis associated with Chediak-Higashi syndrome. J Periodontol 2008: 79: 1263-1270.
14. Barak Y, Nir E. Chediak-Higashi syndrome. Am J Pediatr Hematol Oncol 1987: 9: 42-55.
15. Barr-Agholme M, Dahllof G, Linder L, Modeer T. Actinobacillus actinomycetemcomitans, Capnocytophaga and Porphyromonas gingivalis in subgingival plaque of adolescents with Down's syndrome. Oral Microbiol Immunol 1992: 7: 244-248.
16. Barr-Agholme M, Dahllof G, Modeer T, Engstrom PE, Engstrom GN. Periodontal conditions and salivary immunoglobulins in individuals with Down syndrome. J Periodontol 1998: 69: 1119-1123.
17. Barr-Agholme M, Krekmanova L, Yucel-Lindberg T, Shinoda K, Modeer T. Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 1997: 55: 101-105.
18. Barrett AP, Buckley DJ, Katelaris CH. Oral complications in type 1B glycogen storage disease. Oral Surg Oral Med Oral Pathol 1990: 69: 174-176.
19. Bimstein E, McIlwain M, Katz J, Jerrell G, Primosch R. Aggressive periodontitis of the primary dentition associated with idiopathic immune deficiency: case report and treatment considerations. J Clin Pediatr Dent 2004: 29: 27-31.
20. Bloemers BL, Broers CJ, Bont L, Weijerman ME, Gemke RJ, van Furth AM. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect 2010: 12: 799-808.
21. Bloemers BL, van Bleek GM, Kimpen JL, Bont L. Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr 2010: 156: 804-809, 809 e801-809 e805.
22. Brittain JM, Oldenburg TR, Burkes EJJr. Odontohypophosphatasia: report of two cases. ASDC J Dent Child 1976: 43: 106-111.
23. Carlsson G, Fasth A. Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original 'Kostmann family' and a review. Acta Paediatr 2001: 90: 757-764.
24. Chaushu S, Chaushu G, Zigmond M, Yefenof E, Stabholz A, Shapira J, Merrick J, Bachrach G. Age-dependent deficiency in saliva and salivary antibodies secretion in Down's syndrome. Arch Oral Biol 2007: 52: 1088-1096.
25. Cohen MM, Winer RA, Schwartz S, Shklar G. Oral aspects of mongolism. I. Periodontal disease in mongolism. Oral Surg Oral Med Oral Pathol 1961: 14: 92-107.
26. Dababneh R, Al-Wahadneh AM, Hamadneh S, Khouri A, Bissada NF. Periodontal manifestation of leukocyte adhesion deficiency type I. J Periodontol 2008: 79: 764-768.
27. Dale DC, Hammond WPt. Cyclic neutropenia: a clinical review. Blood Rev 1988: 2: 178-185.
28. Dalgic B, Bukulmez A, Sari S. Eponym: Papillon-Lefèvre syndrome. Eur J Pediatr 2011: 170: 689-691.
29. Deas DE, Mackey SA, McDonnell HT. Systemic disease and periodontitis: manifestations of neutrophil dysfunction. Periodontol 2000 2003: 32: 82-104.
30. Defraia E, Marinelli A. Oral manifestations of congenital neutropenia or Kostmann syndrome. J Clin Pediatr Dent 2001: 26: 99-102.
31. Delcourt-Debruyne EM, Boutigny HR, Hildebrand HF. Features of severe periodontal disease in a teenager with Chediak-Higashi syndrome. J Periodontol 2000: 71: 816-824.
32. Desai SS. Down syndrome: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 84: 279-285.
33. Etzioni A. Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol 2010: 38: 54-60.
34. Falk MJ, Wang H, Traboulsi EI. Cohen syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews™. Seattle, WA: University of Washington, Seattle; 1993- Available from: http://www.ncbi.nlm.nih.gov/books/NBK1116/.
35. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millán JL, MacGregor GR, Whyte MP. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 1999: 14: 2015-2026.
36. Fraser D. Hypophosphatasia. Am J Med 1957: 22: 730-746.
37. Gabre P, Martinsson T, Gahnberg L. Longitudinal study of dental caries, tooth mortality and interproximal bone loss in adults with intellectual disability. Eur J Oral Sci 2001: 109: 20-26.
38. Gardiner K, Slavov D, Bechtel L, Davisson M. Annotation of human chromosome 21 for relevance to Down syndrome: gene structure and expression analysis. Genomics 2002: 79: 833-843.
39. Germeshausen M, Skokowa J, Ballmaier M, Zeidler C, Welte K. G-CSF receptor mutations in patients with congenital neutropenia. Curr Opin Hematol 2008: 15: 332-337.
40. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009: 361: 2033-2045.
41. Halinen S, Sorsa T, Ding Y, Ingman T, Salo T, Konttinen YT, Saari H. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. J Periodontol 1996: 67: 748-754.
42. Hicks J, Wartchow E, Mierau G. Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct Pathol 2011: 35: 183-196.
43. Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 1999: 68: 283-303.
44. Izumi Y, Sugiyama S, Shinozuka O, Yamazaki T, Ohyama T, Ishikawa I. Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction. J Periodontol 1989: 60: 238-242.
45. Kaplan J, De Domenico I, Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol 2008: 15: 22-29.
46. Khocht A, Viera-Negron YE, Ameri A, Abdelsayed R. Periodontitis associated with Chediak-Higashi syndrome in a young African American male. J Int Acad Periodontol 2010: 12: 49-55.
47. Kleinfelder JW, Topoll HH, Preus HR, Muller RF, Lange DE, Bocker W. Microbiological and immunohistological findings in a patient with Papillon-Lefèvre syndrome. J Clin Periodontol 1996: 23: 1032-1038.
48. Komatsu T, Kubota E, Sakai N. Enhancement of matrix metalloproteinase (MMP)-2 activity in gingival tissue and cultured fibroblasts from Down's syndrome patients. Oral Dis 2001: 7: 47-55.
49. Kunkel SL, Remick DG, Spengler M, Chensue SW. Modulation of macrophage-derived interleukin-1 and tumor necrosis factor by prostaglandin E2. Adv Prostaglandin Thromboxane Leukot Res 1987: 17A: 155-158.
50. Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 2009: 156: 189-193.
51. Lana-Elola E, Watson-Scales SD, Fisher EM, Tybulewicz VL. Down syndrome: searching for the genetic culprits. Dis Model Mech 2011: 4: 586-595.
52. Liongue C, Wright C, Russell AP, Ward AC. Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int J Biochem Cell Biol 2009: 41: 2372-2375.
53. Liu R, Cao C, Meng H, Tang Z. Leukocyte functions in 2 cases of Papillon-Lefèvre syndrome. J Clin Periodontol 2000: 27: 69-73.
54. Lundgren T, Parhar RS, Renvert S, Tatakis DN. Impaired cytotoxicity in Papillon-Lefèvre syndrome. J Dent Res 2005: 84: 414-417.
55. Lundgren T, Renvert S. Periodontal treatment of patients with Papillon-Lefèvre syndrome: a 3-year follow-up. J Clin Periodontol 2004: 31: 933-938.
56. Lundgren T, Renvert S, Papapanou PN, Dahlén G. Subgingival microbial profile of Papillon-Lefèvre patients assessed by DNA-probes. J Clin Periodontol 1998: 25: 624-629.
57. Lundgren T, Twetman S, Johansson I, Crossner CG, Birkhed D. Saliva composition in children and young adults with Papillon-Lefèvre syndrome. J Clin Periodontol 1996: 23: 1068-1072.
58. Matarasso S, Daniele V, Iorio Siciliano V, Mignogna MD, Andreuccetti G, Cafiero C. The effect of recombinant granulocyte colony-stimulating factor on oral and periodontal manifestations in a patient with cyclic neutropenia: a case report. Int J Dent 2009: 2009: 654239.
59. Mégarbané A, Ravel A, Mircher C, Sturtz F, Grattau Y, Rethoré MO, Delabar JM, Mobley WC. The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet Med 2009: 11: 611-616.
60. Morgan J. Why is periodontal disease more prevalent and more severe in people with Down syndrome?Spec Care Dentist 2007: 27: 196-201.
61. Morinushi T, Lopatin DE, van Poperin N. The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down's syndrome. J Periodontol 1997: 68: 626-631.
62. Mornet E. The tissue nonspecific alkaline phosphatase gene mutations database, 2012.
63. Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 2011: 75: 439-445.
64. Mrak RE, Griffin WS. Trisomy 21 and the brain. J Neuropathol Exp Neurol 2004: 63: 679-685.
65. Nakai Y, Ishihara C, Ogata S, Shimono T. Oral manifestations of cyclic neutropenia in a Japanese child: case report with a 5-year follow-up. Pediatr Dent 2003: 25: 383-388.
66. Pacheco JJ, Coelho C, Salazar F, Contreras A, Slots J, Velazco CH. Treatment of Papillon-Lefèvre syndrome periodontitis. J Clin Periodontol 2002: 29: 370-374.
67. Page RC, Bowen T, Altman L, Vandesteen E, Ochs H, Mackenzie P, Osterberg S, Engel LD, Williams BL. Prepubertal periodontitis. I. Definition of a clinical disease entity. J Periodontol 1983: 54: 257-271.
68. Page AV, Liles WC. Colony-stimulating factors in the prevention and management of infectious diseases. Infect Dis Clin North Am 2011: 25: 803-817.
69. Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA, Tesselaar K, Koenderman L. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4days. Blood 2010: 116: 625-627.
70. Price PA, Toroian D, Chan WS. Tissue-nonspecific alkaline phosphatase is required for the calcification of collagen in serum: a possible mechanism for biomineralization. J Biol Chem 2009: 284: 4594-4604.
71. Ralls SA, Marshall EC. Dental management of a patient with glycogen storage disease type I. J Am Dent Assoc 1985: 110: 723-726.
72. Reuland-Bosma W, Liem RS, Jansen HW, van Dijk LJ, van der Weele LT. Cellular aspects of and effects on the gingiva in children with Down's syndrome during experimental gingivitis. J Clin Periodontol 1988: 15: 303-311.
73. Reuland-Bosma W, van den Barselaar MT, van de Gevel JS, Leijh PC, de Vries-Huiges H, The HT. Nonspecific and specific immune responses in a child with Down's syndrome and her sibling. A case report. J Periodontol 1988: 59: 249-253.
74. Reuland-Bosma W, van der Reijden WA, van Winkelhoff AJ. Absence of a specific subgingival microflora in adults with Down's syndrome. J Clin Periodontol 2001: 28: 1004-1009.
75. Robertson KL, Drucker DB, James J, Blinkhorn AS, Hamlet S, Bird PS. A microbiological study of Papillon-Lefèvre syndrome in two patients. J Clin Pathol 2001: 54: 371-376.
76. Ryder MI. Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol 2000 2010: 53: 124-137.
77. Saglam F, Atamer T, Onan U, Soydinc M, Kirac K. Infantile genetic agranulocytosis (Kostmann type). A case report. J Periodontol 1995: 66: 808-810.
78. Sakellari D, Arapostathis KN, Konstantinidis A. Periodontal conditions and subgingival microflora in Down syndrome patients. A case-control study. J Clin Periodontol 2005: 32: 684-690.
79. Sakellari D, Belibasakis G, Chadjipadelis T, Arapostathis K, Konstantinidis A. Supragingival and subgingival microbiota of adult patients with Down's syndrome. Changes after periodontal treatment. Oral Microbiol Immunol 2001: 16: 376-382.
80. Santos R, Shanfeld J, Casamassimo P. Serum antibody response to Actinobacillus actinomycetemcomitans in Down's syndrome. Spec Care Dentist 1996: 16: 80-83.
81. Scott DA, Krauss J. Neutrophils in periodontal inflammation. Front Oral Biol 2012: 15: 56-83.
82. Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev 2007: 13: 221-227.
83. Shibutani T, Gen K, Shibata M, Horiguchi Y, Kondo N, Iwayama Y. Long-term follow-up of periodontitis in a patient with Chediak-Higashi syndrome. A case report. J Periodontol 2000: 71: 1024-1028.
84. Shin M, Besser LM, Kucik JE, Lu C, Siffel C, Correa A. Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics 2009: 124: 1565-1571.
85. Sohoel PD, Johannessen AC, Kristoffersen T, Haugstvedt Y, Nilsen R. In situ characterization of mononuclear cells in marginal periodontitis of patients with Down's syndrome. Acta Odontol Scand 1992: 50: 141-149.
86. Søhoel DC, Johannessen AC, Kristoffersen T, Nilsen R. Expression of HLA class II antigens in marginal periodontitis of patients with Down's syndrome. Eur J Oral Sci 1995: 103: 207-213.
87. Søhoel DC, Jonsson R, Johannessen AC, Nilsen R. Gamma/delta T lymphocytes in marginal periodontitis in patients with Down's syndrome. Adv Exp Med Biol 1995: 371B: 1135-1136.
88. Springer TA, Miller LJ, Anderson DC. p150, 95, the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J Immunol 1986: 136: 240-245.
89. Strydom A, Dickinson MJ, Shende S, Pratico D, Walker Z. Oxidative stress and cognitive ability in adults with Down syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2009: 33: 76-80.
90. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005: 76: 2033-2041.
91. Taylor GM. Altered expression of lymphocyte functional antigen in Down syndrome. Immunol Today 1987: 8: 366-369.
92. Taylor GM, Williams A, D'Souza SW, Fergusson WD, Donnai D, Fennell J, Harris R. The expression of CD18 is increased on Trisomy 21 (Down syndrome) lymphoblastoid cells. Clin Exp Immunol 1988: 71: 324-328.
93. Terkeltaub RA. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001: 281: C1-C11.
94. Thase ME. Longevity and mortality in Down's syndrome. J Ment Defic Res 1982: 26: 177-192.
95. Toygar HU, Kircelli C, Firat E, Guzeldemir E. Combined therapy in a patient with Papillon-Lefèvre syndrome: a 13-year follow-up. J Periodontol 2007: 78: 1819-1824.
96. Trigg ME, Schugar R. Chediak-Higashi syndrome: hematopoietic chimerism corrects genetic defect. Bone Marrow Transplant 2001: 27: 1211-1213.
97. Tsilingaridis G, Yucel-Lindberg T, Modeer T. Enhanced levels of prostaglandin E2, leukotriene B4, and matrix metalloproteinase-9 in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 2003: 61: 154-158.
98. Ullbro C, Crossner CG, Nederfors T, Parhar R, Al Mohanna F, Meikle MC, Reynolds JJ, Twetman S. Cytokines, matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome. Acta Odontol Scand 2004: 62: 70-74.
99. Ullbro C, Kinnby B, Lindberg P, Matsson L. Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome. J Clin Periodontol 2004: 31: 708-712.
100. Ulseth JO, Hestnes A, Stovner LJ, Storhaug K. Dental caries and periodontitis in persons with Down syndrome. Spec Care Dentist 1991: 11: 71-73.
101. van den Bos T, Handoko G, Niehof A, Ryan LM, Coburn SP, Whyte MP, Beertsen W. Cementum and dentin in hypophosphatasia. J Dent Res 2005: 84: 1021-1025.
102. Van Dyke TE, Taubman MA, Ebersole JL, Haffajee AD, Socransky SS, Smith DJ, Genco RJ. The Papillon-Lefèvre syndrome: neutrophil dysfunction with severe periodontal disease. Clin Immunol Immunopathol 1984: 31: 419-429.
103. Velazco CH, Coelho C, Salazar F, Contreras A, Slots J, Pacheco JJ. Microbiological features of Papillon-Lefèvre syndrome periodontitis. J Clin Periodontol 1999: 26: 622-627.
104. Ward AC, Dale DC. Genetic and molecular diagnosis of severe congenital neutropenia. Curr Opin Hematol 2009: 16: 9-13.
105. Ward DM, Shiflett SL, Kaplan J. Chediak-Higashi syndrome: a clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med 2002: 2: 469-477.
106. Wei KW, Xuan K, Liu YL, Fang J, Ji K, Wang X, Jin Y, Watanabe S, Watanabe K, Ojihara T. Clinical, pathological and genetic evaluations of Chinese patients with autosomal-dominant hypophosphatasia. Arch Oral Biol 2010: 55: 1017-1023.
107. Whyte MP. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res 2009: 24: 1132-1134.
108. Whyte MP. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 2010: 1192: 190-200.
109. Wong AT, McMillan AS, McGrath C. Oral health-related quality of life and severe hypodontia. J Oral Rehabil 2006: 33: 869-873.
110. Yamazaki-Kubota T, Miyamoto M, Sano Y, Kusumoto M, Yonezu T, Sugita K, Okuda K, Yakushiji M, Ishihara K. Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down's syndrome. J Periodontal Res 2010: 45: 170-176.
111. Yavuzyilmaz E, Ersoy F, Sanal O, Tezcan I, Ercal D. Neutrophil chemotaxis and periodontal status in Down's syndrome patients. J Nihon Univ Sch Dent 1993: 35: 91-95.
112. Yildirim S, Yapar M, Kubar A. Detection and quantification of herpesviruses in Kostmann syndrome periodontitis using real-time polymerase chain reaction: a case report. Oral Microbiol Immunol 2006: 21: 73-78.
113. Zaldivar-Chiapa RM, Arce-Mendoza AY, De La Rosa-Ramirez M, Caffesse RG, Solis-Soto JM. Evaluation of surgical and non-surgical periodontal therapies, and immunological status, of young Down's syndrome patients. J Periodontol 2005: 76: 1061-1065.